SGLT-2 inhibitors linked to lower risk of diabetic foot nerve damage

by American College of Physicians edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes Credit: Pixabay/CC0 Public Domain A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium–glucose cotransporter-2 (SGLT-2) inhibitors have a slightly lower risk of developing diabetic foot problems compared to those taking glucagon-like peptide-1 (GLP-1) receptor agonists. […]

SGLT-2 inhibitors linked to lower risk of diabetic foot nerve damage Read More »